David Roman
Stock Analyst at Goldman Sachs
(3.72)
# 2,095
Out of 4,690 analysts
244
Total ratings
51.7%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $26.13 | -19.63% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $19.72 | -3.65% | 7 | Jul 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $71 → $57 | $46.84 | +21.69% | 11 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $21 → $16 | $21.43 | -25.34% | 7 | Jul 14, 2026 | |
| BLCO Bausch + Lomb | Maintained: Hold | $19 → $21 | $17.15 | +22.45% | 4 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $11.34 | +173.37% | 2 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $95 → $98 | $90.21 | +8.64% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $372.60 | +49.76% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Maintained: Buy | $26 → $25 | $23.69 | +5.53% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Maintained: Hold | $84 → $83 | $91.23 | -9.02% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $24 | $20.10 | +19.40% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $113 | $112.47 | +0.47% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $89 → $88 | $96.37 | -8.69% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $73 → $61 | $71.17 | -14.29% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $237 → $205 | $145.13 | +41.25% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $6.50 | +23.08% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $179.87 | -14.94% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $90.82 | -11.91% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $26.73 | -10.21% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $21.16 | -5.48% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $72 | $80.32 | -10.36% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $50 | $35.28 | +41.72% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $54 → $66 | $91.12 | -27.57% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $16.88 | -5.21% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $357 → $361 | $330.69 | +9.17% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $147 | $120.25 | +22.25% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $71.73 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $189.52 | -11.88% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $25.64 | -33.70% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $93 → $88 | $100.91 | -12.79% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $103.96 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $82.97 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $103 | $109.55 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $15 | $10.19 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $26.13
Upside: -19.63%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $19.72
Upside: -3.65%
Boston Scientific
Jul 14, 2026
Maintained: Buy
Price Target: $71 → $57
Current: $46.84
Upside: +21.69%
Tandem Diabetes Care
Jul 14, 2026
Maintained: Hold
Price Target: $21 → $16
Current: $21.43
Upside: -25.34%
Bausch + Lomb
Jul 14, 2026
Maintained: Hold
Price Target: $19 → $21
Current: $17.15
Upside: +22.45%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $11.34
Upside: +173.37%
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $95 → $98
Current: $90.21
Upside: +8.64%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $372.60
Upside: +49.76%
Omada Health
Jun 10, 2026
Maintained: Buy
Price Target: $26 → $25
Current: $23.69
Upside: +5.53%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $84 → $83
Current: $91.23
Upside: -9.02%
Jun 3, 2026
Maintained: Buy
Price Target: $14 → $24
Current: $20.10
Upside: +19.40%
May 31, 2026
Maintained: Buy
Price Target: $121 → $113
Current: $112.47
Upside: +0.47%
May 29, 2026
Maintained: Sell
Price Target: $89 → $88
Current: $96.37
Upside: -8.69%
May 27, 2026
Maintained: Sell
Price Target: $73 → $61
Current: $71.17
Upside: -14.29%
May 27, 2026
Maintained: Buy
Price Target: $237 → $205
Current: $145.13
Upside: +41.25%
May 27, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $6.50
Upside: +23.08%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $179.87
Upside: -14.94%
May 15, 2026
Maintained: Buy
Price Target: $80
Current: $90.82
Upside: -11.91%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $26.73
Upside: -10.21%
May 13, 2026
Maintained: Buy
Price Target: $20
Current: $21.16
Upside: -5.48%
May 6, 2026
Maintained: Hold
Price Target: $73 → $72
Current: $80.32
Upside: -10.36%
May 6, 2026
Maintained: Buy
Price Target: $54 → $50
Current: $35.28
Upside: +41.72%
May 5, 2026
Maintained: Sell
Price Target: $54 → $66
Current: $91.12
Upside: -27.57%
May 5, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $16.88
Upside: -5.21%
May 1, 2026
Maintained: Hold
Price Target: $357 → $361
Current: $330.69
Upside: +9.17%
Apr 30, 2026
Maintained: Hold
Price Target: $147
Current: $120.25
Upside: +22.25%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $71.73
Upside: -
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $189.52
Upside: -11.88%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $25.64
Upside: -33.70%
Feb 10, 2026
Maintained: Sell
Price Target: $93 → $88
Current: $100.91
Upside: -12.79%
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $103.96
Upside: n/a
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $82.97
Upside: n/a
Nov 15, 2013
Maintained: Sell
Price Target: $103
Current: $109.55
Upside: n/a
Aug 30, 2012
Maintained: Hold
Price Target: $44 → $15
Current: $10.19
Upside: n/a